Role of platelet-activating factor on extravascular lung water after coronary reperfusion in dogs

Japanese Journal of Physiology

Volumn 48, Issue 2, 1998, Pages 157-161

  Izuoka, Toshio ^a   Takayama, Yasuo ^a   Sugiura, Tetsuro ^a   Taniguchi, Hiroya ^a   Tamura, Teruhiro ^a   Kitashiro, Shuji ^a   Jikuhara, Toshimitsu ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Dog; Extravascular lung water; Pulmonary edema; Reperfusion

Indexed keywords

3 BROMO 5 [N PHENYL N [2 [[2 (1,2,3,4 TETRAHYDRO 2 ISOQUINOLYLCARBONYLOXY)ETHYL]CARBAMOYL]ETHYL]CARBAMOYL] 1 PROPYLPYRIDINIUM NITRATE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CORONARY REPERFUSION; DOG; HEMODYNAMICS; LUNG EDEMA; LUNG EXTRAVASCULAR FLUID; NONHUMAN; REPERFUSION;

ANIMALS; CORONARY VESSELS; DOGS; EXTRAVASCULAR LUNG WATER; HEMODYNAMIC PROCESSES; ISOQUINOLINES; LIGATION; MYOCARDIAL REPERFUSION; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; PYRIDINIUM COMPOUNDS; TETRAHYDROISOQUINOLINES;

EID: 0031827020     PISSN: 0021521X     EISSN: None     Source Type: Journal    
DOI: 10.2170/jjphysiol.48.157     Document Type: Article

References (33)

1. Braunwald E and Kloner RA: Myocardial reperfusion a double-edged sword? J Clin Invest 76 1713-1719, 1985
2. Opie LH and Coetzee WA: Role of calcium ions in reperfusion arrhythmias Relevance to pharmacologic intervention. Cardiovasc Drugs Ther 2: 623-636, 1988
3. Zimmerman ANE and Hulsmann WC: Paradoxical influence of calcium ions on permeability of the isolated rat heart Nature 211: 646-647, 1960
4. Taniguchi H, Iwasaka T, Takayama Y, Sugiura T, and Inada M: Role of platelet-activating factor in pulmonary edema after coronary ligation in dogs Chest 102, 1245-1250, 1992
5. Opie LH and Phil D Reperfusion injury and its pharmacologic modification Circulation 80: 1049-1062, 1989
6. Gray BA, Beckett RC, Allison RC, McCaffree R, Smith RM, and Sivak ED. Effect of edema and hemodynamic changes on extravascular thermal volume of the lung. J Appl Physiol 56 878-890, 1984
7. Mihm FG, Feeley TW, Rosenthal MH, and Lewis F: Measurement of extravascular lung water in dogs using the thermal-green dye indicator dilution method Anesthesiology 57, 116-122, 1982
8. Allison RC, Carlile PV, and Gray BA Thermodilution measurement of lung water. Clin Chest Med 6: 439-457, 1985
9. Ginks WR, Sybers HD, and Maroko PR. Coronary artery reperfusion: II Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest 51: 2717-2723, 1972
10. Smith GT, Soeter JR, Haston HH, and McNamara JJ: Coronary reperfusion in primates: serial electrocardiographic and histologic assessment J Clin Invest 54: 1420-1427, 1974
11. Deloche A, Fabiani JN, and Camilleri JP. The effect of coronary artery reperfusion on the extent of myocardial infarction. Am Heart J 93: 358-366, 1977
12. Bergmann SR, Lerch RA, Fox KAA, Ludbrock PA, Welch MJ, Terpogossian MM, and Sobel BE: The temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography Am J Med 73: 573-581, 1982
13. Anderson JL, Marshall HW, Bay BE, Bray BE, Lutz JR, Frederick PR, Yanowitz FG, Datz FL, Klausner SC, and Hagan AD: A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med 308: 1312-1318, 1983
14. Ganote CE and Humphrey SM Effects of anoxic or oxygenated reperfusion in globally ischemic, isovolumic perfused rat hearts. Am J Pathol 120 129-145, 1985
15. Guarnieri C, Flamigini F, and Caldarera CM: Role of oxygen in the cellular damage induced by re-oxygenation of hypoxic heart. J Mol Cell Cardiol 12: 797-808,1980
16. Cutillo AG: The clinical assessment of lung water. Chest 92: 319-325, 1987
17. Bolli R: Mechanism of myocardial "stunning." Circulation 82: 723-738, 1990
18. Takayama Y, Iwasaka T Sugiura T, Sumimoto T, Takeuchi M, Tsuji H, Takashima H, Taniguchi H, and Inada M: Increased extravascular lung water with low pulmonary capillary occlusion pressure after acute myocardial infarction. Crit Care Med 19: 21-25, 1991
19. Effros RM: Lung water measurements with the mean transit time approach. J Appl Physiol 59: 673-683, 1985
20. Braquet P, Touqui J, Shen TY, and Vargafig BB: Perspectives in platelet-activating factor research. Pharmacol Rev 39: 97-145, 1987
21. Braquet P, Braquet MP, Koltai M, Bourgain R, Bussolino F, and Hosford D: Is there a case for PAF antagonists in the treatment of ischemic states? Trends Pharmacol Sci 10, 23-30, 1989
22. Sessler CN, Glauser FL, Davis D, and Flower AA. Effects of platelet-activating factor antagonist SRI-63-441 on endotoxemia in sheep. J Appl Physiol 65: 2624-2631, 1988
23. Olson NC, Joyce PB, and Fleisher LN: Role of platelet-activating factor and eicosanoids during endotoxin-induced lung injury in pigs. Am J Physiol 258: H1674-H1686, 1990
24. Chang SW, Fernyak S, and Voelkel NF: Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury Am J Physiol 258: H153-H158, 1990
25. Maruyama M, Farber NE, Vercellotti GM, and Jacob HS, and Gross FJ: Evidence for a role of activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs. Am Heart J 120 510-520, 1990
26. Terashita Z, Kawamura M, Takatani M, Tsushima S, Imura Y, and Nishikawa K: Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic in rodents. J Pharmacol Exp Ther 260, 748-755, 1992
27. Tamura K, Kimura Y, Tamura T, Kitashiro S, Izuoka T, Tsuji H, Iwasaka T, and Inada M: The effect of platelet-activating-factor antagonist TCV-309 on arrhythmias and functional recovery during myocardial reperfusion. Coron Artery Dis 5: 267-273, 1994
28. Takatani M, Maezaki N, Imura Y, Terashita Z, Nishikawa K, and Tsushima S: Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309. Adv Prost. Thomb Leuko Res 21: 943-946, 1991
29. Burhop KE, van-der-Zee H, Bizios HR, Kaplan JE, and Malik AB: Pulmonary vascular response to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites Am Rev Respir Dis 134: 548-554, 1986
30. Christman BW, Lefferts PL, King GA, and Snaper JR: Role of circulating platelets and granulocytes in PAF-induced pulmonary dysfunction awake sheep J Appl Physiol 64 2033-2041, 1988
31. Kenzora JL, Perez JE, Bergman SR, and Lange LG: Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, after-load, and contractility in dogs. J Clin Invest 74: 1193-1203, 1984
32. Accurso FJ, Abman SH, Wilkenig RB, Worthen GS, and Henson P: Fetal pulmonary vasodilation exogenous platelet-activating factor J Appl Physiol 70: 778-787, 1991
33. Montrucchio G, Alloatti G, Tetta C, Deluca R, Saunders RN, Emanuelli G, and Camussi G. Release of platelet-activating factor from ischemic-reperfused rabbit heart. J Appl Physiol 68 H1236-H1246, 1989